As a developer and manufacturer of pharmaceutical ingredients, our company specializes in delivering high-quality generic active pharmaceutical ingredients (APIs) and intermediates to support global drug production. With decades of expertise, we prioritize precision, scalability, and compliance to empower pharmaceutical partners in creating accessible, safe, and effective therapies. Our portfolio spans advanced fluorinated APIs, highly active API (HPAPI)s, deuterated intermediates, fluorinated intermediates and more, designed to meet the evolving needs of modern medicine.
Overview of Generic APIs and Intermediates
Generic APIs are the core therapeutic components in off-patent medications, ensuring bioequivalence to branded drugs while reducing costs. Intermediates, on the other hand, are critical building blocks synthesized during API production. Together, these components form the backbone of generic drug manufacturing, enabling streamlined synthesis, regulatory compliance, and large-scale commercialization.
Fig.1 General method for the biocatalytic synthesis of (S)-omeprazole employing BVMOs. (García-Fernández, et al., 2023).
Our offerings include common APIs and pharmaceutical intermediates, as well as specialized categories such as fluorinated APIs for enhanced metabolic stability, HPAPIs for targeted therapies, and deuterated intermediates to improve drug pharmacokinetics. By integrating innovative chemistry with stringent quality controls, we ensure these products meet pharmacopeial standards and adapt to diverse formulation requirements.
Explore Our Products
We offer a focused set of generic APIs, including Fluorinated APIs, Highly-Active APIs (HPAPIs), and Other Generic APIs built on well-established scaffolds, with routes engineered for reproducibility, impurity control, and practical scale-up. Each product is delivered with clear specifications to support pharmaceutical laboratory research, process development, and method establishment.
We offer a concise, research-focused portfolio of small-molecule intermediates—deuterated and fluorinated fragments, chiral building blocks, carbonyl units, and selected heterocycles—chosen to streamline route scouting and scale-aware process development. Each item is backed by reproducible synthesis, impurity-profile control, and clear specifications with analytical data. All materials are intended to support laboratory research, process development, and analytical method establishment in pharmaceutical R&D contexts.
- Deuterated and Fluorinated fragments: Tune lipophilicity, pKa, and conformational bias to refine target engagement and stability in discovery workflows.
- Chiral building blocks: Provide defined stereochemistry to simplify asymmetric routes and secure enantiopure outcomes.
- Carbonyl units (aldehydes/ketones/acids/esters): Serve as versatile coupling handles for rapid scaffold diversification.
- Heterocycles: Supply drug-like cores (e.g., pyridines, imidazoles, quinazolines) that underpin many lead-series frameworks.
Additionally, we provide intermediates for agrochemical applications, reflecting our versatility across industries.
From fluorinated compounds that redefine drug stability to deuterated intermediates paving the way for next-generation therapies, our portfolio of generic APIs and intermediates bridges the gap between innovation and accessibility. We remain committed to advancing pharmaceutical science through relentless quality improvement and collaborative partnerships.
Reference
- García-Fernández, P. D.; et al. Green oxidative catalytic processes for the preparation of APIs and precursors. Catalysts. 2023, 13(3): 638.